
|Articles|September 12, 2019
CROMSOURCE Consolidates Hybrid Services Model
Advertisement
CROMSOURCE has announced consolidation of its Hybrid Services Model and refined it to be able to provide its pharmaceutical, medical device, and biotechnology clients with an efficient alternative to traditional fully outsourced or functional service provider models.
To learn more, click
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Site Relationships and Payment Reliability, AI Adoption Without Governance Risk, and China's Biotech Innovation Rise
2
ACT Brief: AI in Invoice Processing, Botanical Medicines and FDA Pathways, and Connected Trial Finance Systems
3
Inspection Readiness Is Not a Pre-Inspection Activity, It's an Execution Design Condition
4
Navigating the Adoption of Biomarker-Informed Trial Enrollment Beyond Oncology
5




